natgillin/translations-raw huggingface dataset:
Insulin requirements may be altered during intercurrent conditions such as illness, emotional disturbances, or stress.
Potrebe po insulinu se lahko spremenijo med interkurentnimi stanji, na primer boleznimi, čustvenimi motnjami ali stresom.
Insulin requirements may be increased by substances with hyperglycaemic activity, such as oral contraceptives, corticosteroids, or thyroid replacement therapy, danazol, beta2 stimulants (such as ritodrine, salbutamol, terbutaline).
Potrebe po insulinu lahko povečajo zdravila s hiperglikemičnim delovanjem, kot so peroralni kontraceptivi, kortikosteroidi ali nadomestno zdravljenje s ščitničnimi hormoni, danazol, stimulatorji receptorjev beta2 (na primer ritodrin, salbutamol, terbutalin).
Insulin requirements may be reduced in patients with hepatic impairment due to reduced capacity for gluconeogenesis and reduced insulin breakdown; however, in patients with chronic hepatic impairment, an increase in insulin resistance may lead to increased insulin requirements
Potrebe po insulinu so lahko zmanjšane tudi pri bolnikih z jetrno okvaro zaradi zmanjšane zmogljivosti za glukoneogenezo in zmanjšane razgradnje insulina, vendar pa lahko pri bolnikih s kronično jetrno okvaro povečanje rezistence na insulin vodi v povečano potrebo po insulinu.
Insulin requirements may be reduced in patients with hepatic impairment due to reduced capacity for gluconeogenesis and reduced insulin breakdown; however, in patients with chronic hepatic impairment, an increase in insulin resistance may lead to increased insulin requirements.
Potrebe po insulinu so lahko zmanjšane tudi pri bolnikih z jetrno okvaro zaradi zmanjšane zmogljivosti za glukoneogenezo in zmanjšane razgradnje insulina, vendar pa lahko pri bolnikih s kronično jetrno okvaro povečanje rezistence na insulin vodi v povečano potrebo po insulinu.
Insulin requirements may be reduced in the presence of medicinal products with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta-blockers, octreotide or alcohol.
Potrebe po insulinu lahko zmanjšajo zdravila s hipoglikemičnim delovanjem, kot so peroralni antidiabetiki, salicilati (na primer acetilsalicilna kislina), sulfonamidi, nekateri antidepresivi (zaviralci monoamin-oksidaze, selektivni zaviralci prevzema serotonina), nekateri zaviralci angiotenzin- konvertaze (kaptopril, enalapril), blokatorji receptorjev angiotenzina II, beta blokatorji, oktreotid ali alkohol.
Insulin requirements may be reduced in the presence of medicinal products with hypoglycaemic activity, such as oral hypoglycemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta-blockers, octreotide or alcohol.
Potrebe po insulinu lahko zmanjšajo zdravila s hipoglikemičnim delovanjem, kot so peroralni antidiabetiki, salicilati (na primer acetilsalicilna kislina), sulfonamidi, nekateri antidepresivi (zaviralci monoamin-oksidaze, selektivni zaviralci prevzema serotonina), nekateri zaviralci angiotenzin- konvertaze (kaptopril, enalapril), blokatorji receptorjev angiotenzina II, beta blokatorji, oktreotid ali alkohol.
Insulin requirements may be reduced in the presence of renal impairment.
Pri okvarjenem delovanju ledvic so potrebe po insulinu lahko zmanjšane.
Insulin requirements may be reduced in the presence of renal impairment.
V prisotnosti ledvične okvare so lahko potrebe po insulinu zmanjšane.
Insulin requirements may be reduced in the presence of substances with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta- blockers, octreotide or alcohol.
Potrebe po insulinu lahko zmanjšajo zdravila s hipoglikemičnim delovanjem, kot so peroralni antidiabetiki, salicilati (na primer acetilsalicilna kislina), sulfonamidi, nekateri antidepresivi (zaviralci monoamin-oksidaze, selektivni zaviralci prevzema serotonina), nekateri zaviralci angiotenzin- konvertaze (kaptopril, enalapril), blokatorji receptorjev angiotenzina II, beta blokatorji, oktreotid ali alkohol.
Insulin requirements may be reduced in the presence of substances with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants, (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta- blockers, octreotide or alcohol.
Potrebe po insulinu lahko zmanjšajo zdravila s hipoglikemičnim delovanjem, kot so peroralni antidiabetiki, salicilati (na primer acetilsalicilna kislina), sulfonamidi, nekateri antidepresivi (zaviralci monoamin-oksidaze, selektivni zaviralci prevzema serotonina), nekateri zaviralci angiotenzin- konvertaze (kaptopril, enalapril), blokatorji receptorjev angiotenzina II, beta blokatorji, oktreotid ali alkohol.
Insulin requirements may be reduced in the presence of substances with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulphate antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta- blockers, octreotide or alcohol.
Potrebe po insulinu lahko zmanjšajo zdravila s hipoglikemičnim delovanjem, kot so peroralni antidiabetiki, salicilati (na primer acetilsalicilna kislina), sulfonamidi, nekateri antidepresivi (zaviralci monoamin-oksidaze, selektivni zaviralci prevzema serotonina), nekateri zaviralci angiotenzin- konvertaze (kaptopril, enalapril), blokatorji receptorjev angiotenzina II, beta blokatorji, oktreotid ali alkohol.
Insulin requirements may be reduced in the presence of substances with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulphate antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta- blockers, octreotide, or alcohol.
Potrebe po insulinu lahko zmanjšajo zdravila s hipoglikemičnim delovanjem, kot so peroralni antidiabetiki, salicilati (na primer acetilsalicilna kislina), sulfonamidi, nekateri antidepresivi (zaviralci monoamin-oksidaze, selektivni zaviralci prevzema serotonina), nekateri zaviralci angiotenzin- konvertaze (kaptopril, enalapril), blokatorji receptorjev angiotenzina II, beta blokatorji, oktreotid ali alkohol.
Insulin requirements usually decrease in the first trimester and increase subsequently during the second and third trimester.
Potreba po insulinu se v prvem trimesečju ponavadi zmanjša, potem pa se v drugem in tretjem trimesečju zveča.
Insulin requirements usually fall in the first trimester and subsequently increase during the second and third trimesters.
Potreba po insulinu se v prvem trimesecju ponavadi zmanjša, potem pa se v drugem in tretjem trimesecju zveca.
Insulin resistance*
rezistenca na insulin
Insulin scale Insulin window
merilo preostanka insulina insulinsko okence
INSULIN SECRETAGOGUES
INSULINSKI SEKRETAGOGI
INSULIN SECRETAGOGUES
NARKOTIČNI ANALGETIKI
Insulin secretion/beta-cell function
Izločanje insulina/delovanje celic beta
Insulin solutions should not be used if they do not appear water clear and colourless.
Raztopin insulina se ne sme uporabiti, ce niso bistre kot voda in brezbarvne.
Insulin that you inject in such a site may not work very well.
Lahko se zgodi, da insulin, ki ga boste injicirali na tako spremenjeno mesto, ne bo deloval dobro.
Insulin treatment may also cause temporary build-up of water in the body with swelling in the calves and ankles.
Zdravljenje z insulinom lahko povzroči tudi začasno kopičenje vode v telesu z otekanjem meč in gležnjev.
Insulin treatment may cause temporary build-up of water in the body with swelling in the calves and ankles.
Zdravljenje z insulinom lahko povzroči prehodno kopičenje vode v telesu in posledično otekanje meč in gležnjev.
Insulin treatment of the nursing mother presents no risk to the baby.
Zdravljenje dojece matere z insulinom ne pomeni nobene nevarnosti za dojencka.
Insulin treatment of the nursing mother presents no risk to the baby.
Zdravljenje doječe matere z insulinom ne pomeni nobene nevarnosti za dojenčka.
Insulin under-delivery
Nezadostno dovajanje insulina
Insulin users
Uporabniki insulina
Insulin with a rapid onset and short duration of action
Insulin s hitrim začetkom in kratkim trajanjem delovanja.
insulin, either on its own or together with metformin.
insulin, bodisi kot samostojno zdravilo bodisi skupaj z metforminom.
insulin; metformin, liraglutide, vildagliptin, nateglinide (antidiabetic medicines).
insulin; metformin, liraglutid, vildagliptin, nateglinid (antidiabetiki).
Insulins of different concentration (e.g.
Insulinov različne koncentracije (npr.
Insuman
EU/1/97/030/085
Insuman
EU/1/97/030/149
Insuman Basal
Insuman Basal 100 i.e./ml
Insuman Basal (an isophane insulin suspension) is an insulin with gradual onset and long duration of action.
Insuman Basal (suspenzija insulina izofana) je insulin s postopnim začetkom in dolgim trajanjem delovanja.
Insuman Basal 100 IU/ml suspension for injection in a cartridge
Insuman Basal 100 i.e./ml suspenzija za injiciranje v vložku
Insuman Basal 100 IU/ml suspension for injection in a cartridge for OptiClik Insulin human
Insuman Basal 100 i.e./ml suspenzija za injiciranje v vložku za OptiClik humani insulin
Insuman Basal 100 IU/ml suspension for injection in a cartridge for OptiClik.
Insuman Basal 100 i.e./ml suspenzija za injiciranje v vložku za OptiClik
Insuman Basal 100 IU/ml suspension for injection in a cartridge Insulin human
Insuman Basal 100 i.e./ml suspenzija za injiciranje v vložku humani insulin
Insuman Basal 100 IU/ml suspension for injection in a pre-filled pen Insulin human
Insuman Basal 100 i.e./ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin
Insuman Basal 100 IU/ml suspension for injection in a pre-filled pen.
Insuman Basal 100 i.e./ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
Insuman Basal 100 IU/ml suspension for injection in a vial
Insuman Basal 100 i.e./ml suspenzija za injiciranje v viali
Insuman Basal 100 IU/ml suspension for injection Insulin human
Insuman Basal 100 i.e./ml suspenzija za injiciranje humani insulin
Insuman Basal 40
Insuman Basal 40 i.e./ml
Insuman Basal 40 IU/ml suspension for injection in a vial
Insuman Basal 40 i.e./ml suspenzija za injiciranje v viali
Insuman Basal 40 IU/ml suspension for injection Insulin human
Insuman Basal 40 i.e./ml suspenzija za injiciranje humani insulin
Insuman Basal can be used during breast-feeding.
Zdravilo Insuman Basal je med dojenjem dovoljeno uporabljati.
Insuman Basal cartridges are not designed to allow any other insulin to be mixed in the cartridge.
Vložki Insuman Basal niso zasnovani tako, da bi dovoljevali mešanje kakšnega drugega insulina v vložku.
Insuman Basal cartridges for OptiClik are not designed to allow any other insulin to be mixed in the cartridge for OptiClik.
Vložki Insuman Basal za injekcijski peresnik OptiClik niso zasnovani tako, da bi dovoljevali mešanje kakšnega drugega insulina v vložku za injekcijski peresnik OptiClik.
Insuman Basal comes in a cartridge sealed in a plastic container, which is the disposable part of OptiClik, an insulin pen.
Zdravilo Insuman Basal je na voljo v vložkih, zapečatenih v plastičnih vsebnikih, ki so namenjeni uporabi z insulinskim injekcijskim peresnikom OptiClik.
Insuman Basal comes in cartridges sealed in disposable pen injectors, OptiSet.
Insuman Basal je na voljo v vložkih, zapečatenih v injekcijskih peresnikih,OptiSet, za enkratno uporabo.
Insuman Basal contains the active substance insulin human which is made by a biotechnology process and is identical with the body's own insulin.
Insuman Basal je vsebuje zdravilno učinkovino humani insulin, ki je pridobljen biotehnološko in je popolnoma enak lastnemu telesnemu insulinu.
Insuman Basal contains the active substance insulin human which is made by a biotechnology process and is identical with the body's own insulin.
Zdravilo Insuman vsebuje zdravilno učinkovino humani insulin, ki je pridobljen biotehnološko in je popolnoma enak lastnemu telesnemu insulinu.
Insuman Basal in cartridges for OptiClik has been developed for use with OptiClik only.
Insuman Basal v vložkih za injekcijski peresnik OptiClik je pripravljen samo za uporabo v injekcijskih peresnikih OptiClik.
Insuman Basal is a fluid (suspension) for injection under the skin.
Insuman Basal je tekočina (suspenzija) za injiciranje pod kožo
Insuman Basal is an insulin preparation with a gradual onset and long duration of action.
Insuman Basal je raztopina insulina s postopnim začetkom in dolgim trajanjem delovanja.
Insuman Basal is an insulin preparation with a gradual onset and long duration of action.
Zdravilo Insuman Basal je insulinski pripravek s postopnim začetkom in dolgim trajanjem delovanja.
Insuman Basal is injected under the skin 45 to 60 minutes before a meal.
Insuman Basal injicirajte podkožno od 45 do 60 minut pred obrokom.
Insuman Basal is injected under the skin 45 to 60 minutes before a meal.
Zdravilo Insuman Basal injicirajte podkožno od 45 do 60 minut pred obrokom.
Insuman Basal is supplied in cartridges for OptiClik containing 3 ml suspension (300 IU).
Zdravilo Insuman Basal je na voljo v vložkih, ki vsebujejo 3 ml suspenzije (300 i.e.).
Insuman Basal is supplied in pre-filled pens, OptiSet, containing 3 ml suspension (300 IU).
Insuman Basal je na voljo v napolnjenih injekcijskih peresnikih, OptiSet, ki vsebujejo 3 ml raztopine (300 i.e.).
Insuman Basal is supplied in pre-filled pens, SoloStar, containing 3 ml suspension (300 IU).
Insuman Basal je na voljo v napolnjenih injekcijskih peresnikih SoloStar. ki vsebujejo 3 ml raztopine (300 i.e.).
Insuman Basal is used to reduce high blood sugar in patients with diabetes mellitus who need treatment with insulin.
Zdravilo Insuman Basal se uporablja za znižanje visokega krvnega sladkorja pri bolnikih s sladkorno boleznijo, ki potrebujejo zdravljenje z insulinom.
Insuman Basal may be mixed with all insulin human formulation, but not with those designed specifically for use in insulin pumps.
Insuman Basal se sme mešati z vsemi humanimi insulini, razen s tistimi, ki so posebej pripravljeni za uporabo v insulinskih črpalkah.
Insuman Basal may be mixed with all insulin human formulations, but not with those designed specifically for use in insulin pumps.
Insuman Basal se sme mešati z vsemi humanimi insulini, razen s tistimi, ki so posebej pripravljeni za uporabo v insulinskih črpalkah.
Insuman Basal must also not be mixed with insulins of animal origin or with insulin analogues.
Zdravila Insuman Basal se prav tako ne sme mešati z insulini živalskega izvora ali insulinskimi analogi.
Insuman Basal must not be mixed with any other insulin or with insulin analogues.
Insuman Basal se ne sme mešati z nobenim drugim insulinom ali insulinskimi analogi.
Insuman Basal must not be mixed with insulin human formulations designed specifically for use in insulin pumps.
Zdravila Insuman Basal se sme mešati z humanimi insulini, ki so posebej pripravljeni za uporabo v insulinskih črpalkah.
Insuman Basal must not be mixed with solutions containing reducing substances such as thioles and sulphites.
Zdravila Insuman Basal se ne sme mešati z raztopinami, ki vsebujejo reducente, npr. tiole ali sulfite.
Insuman Basal must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insulina Insuman Basal se ne sme uporabiti, če tega ni mogoče doseči – če suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno vložka.
Insuman Basal must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insulina Insuman Basal se ne sme uporabiti, če tega ni mogoče doseči, tj. suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno vložka.
Insuman Basal must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the vial.
Insulina Insuman Basal se ne sme uporabiti, če tega ni mogoče doseči – če suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno viale.
Insuman Basal must not be used in external or implanted insulin pumps or in peristaltic pumps with silicone tubing.
Insulina Insuman Basal se ne sme dajati intravensko in se ga ne sme uporabljati v infuzijskih črpalkah ali v zunanjih ali vsajenih insulinskih črpalkah.
Insuman Basal OptiSet
Insuman Basal 100 i.e./ml OptiSet
Insuman Basal SoloStar
Insuman Basal 100 i.e./ml SoloStar.
Insuman Basal SoloStar 100 IU/ml suspension for injection in a pre-filled pen Insulin human
Insuman Basal SoloStar 100 i.e./ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin
Insuman Basal SoloStar 100 IU/ml suspension for injection in a pre-filled pen.
Insuman Basal SoloStar 100 i.e./ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
Insuman Basal SoloStar 100 IU/ml suspension for injection Insulin human
Insuman Basal SoloStar 100 i.e./ml suspenzija za injiciranje humani insulin
Insuman Basal suspension for injection in a pre-filled pen.
Insuman Basal suspenzija za injiciranje v napolnjenem injekcijskem peresniku.
Insuman Basal with alcohol
Zdravilo Insuman Basal skupaj z alkoholom
Insuman Basal, an intermediate-acting insulin suspension containing isophane insulin;
Insuman Basal, suspenzijo insulinov s srednje dolgim delovanjem, ki vsebuje insulin izofan;
Insuman Basal, pre-filled pen, OptiSet, is not designed to allow any other insulin to be mixed in the cartridge.
Insuman Basal, napolnjen injekcijski peresnik, OptiSet, ni narejen tako, da bi dopuščal mešanje kakšnega drugega insulina v vložku.
Insuman Comb 15
EU/1/97/030/046
Insuman Comb 15
Insuman Comb 15 100 i.e./ml
Insuman Comb 15 100
Insuman Comb 15 100 i.e./ml
Insuman Comb 15 100 IU/ml suspension for injection in a cartridge
Insuman Comb 15 100 i.e./ml suspenzija za injiciranje v vložku
Insuman Comb 15 100 IU/ml suspension for injection in a cartridge for OptiClik Insulin human
Insuman Comb 15 100 i.e./ml suspenzija za injiciranje v vložku za OptiClik humani insulin
Insuman Comb 15 100 IU/ml suspension for injection in a cartridge for OptiClik.
Insuman Comb 15 100 i.e./ml suspenzija za injiciranje v vložku za OptiClik
Insuman Comb 15 100 IU/ml suspension for injection in a pre-filled pen Insulin human
Insuman Comb 15 100 i.e./ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku humani insulin
Insuman Comb 15 100 IU/ml suspension for injection in a pre-filled pen.
Insuman Comb 15 100 i.e./ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
Insuman Comb 15 100 IU/ml suspension for injection in a vial
Insuman Comb 15 100 i.e./ml suspenzija za injiciranje v viali
Insuman Comb 15 100 IU/ml suspension for injection Insulin human
Insuman Comb 15 100 i.e./ml suspenzija za injiciranje humani insulin
Insuman Comb 15 40
Insuman Comb 15 40 i.e./ml
Insuman Comb 15 40 IU/ml suspension for injection in a vial
Insuman Comb 15 40 i.e./ml suspenzija za injiciranje v viali
Insuman Comb 15 40 IU/ml suspension for injection in a vial Insulin human
Insuman Comb 15 40 i.e./ml suspenzija za injiciranje v viali humani insulin
Insuman Comb 15 40 IU/ml suspension for injection Insulin human
Insuman Comb 15 40 i.e./ml suspenzija za injiciranje humani insulin
Insuman Comb 15 cartridges are not designed to allow any other insulin to be mixed in the cartridge.
Vložki Insuman Comb 15 niso zasnovani tako, da bi dovoljevali mešanje kakšnega drugega insulina v vložku.
Insuman Comb 15 cartridges for OptiClik are not designed to allow any other insulin to be mixed in the cartridge for OptiClik.
Vložki Insuman Comb 15 za injekcijski peresnik OptiClik niso zasnovani tako, da bi dovoljevali mešanje kakšnega drugega insulina v vložku za injekcijski peresnik OptiClik.
Insuman Comb 15 comes in a cartridge sealed in a plastic container, which is the disposable part of OptiClik, an insulin pen.
Zdravilo Insuman Comb 15 je na voljo v vložkih, zapečatenih v plastičnih vsebnikih, ki so namenjeni uporabi z insulinskim injekcijskim peresnikom OptiClik.
Insuman Comb 15 comes in cartridges sealed in disposable pen injectors, OptiSet.
Insuman Comb 15 je na voljo v vložkih, zapečatenih v injekcijskih peresnikih, OptiSet, za enkratno uporabo.
Insuman Comb 15 contains 40 IU insulin per ml.
Insuman Comb 15 vsebuje 40 i.e. insulina na mililiter.
Insuman Comb 15 contains the active substance insulin human which is made by a biotechnology process and is identical with the body's own insulin.
Insuman Comb 15 vsebuje zdravilno učinkovino humani insulin, ki je pridobljen biotehnološko in je popolnoma enak lastnemu telesnemu insulinu .
Insuman Comb 15 contains the active substance insulin human which is made by a biotechnology process and is identical with the body's own insulin.
Zdravilo Insuman Comb 15 vsebuje zdravilno učinkovino humani insulin, ki je pridobljen biotehnološko in je popolnoma enak lastnemu telesnemu insulinu.
Insuman Comb 15 in cartridges for OptiClik has been developed for use with OptiClik only.
Insuman Comb 15 v vložkih za injekcijski peresnik OptiClik je pripravljen samo za uporabo v injekcijskih peresnikih OptiClik.
Insuman Comb 15 in cartridges for OptiClik has been developed for use with OptiClik only.
Vložki se uporabljajo samo z injekcijskim peresnikom OptiClik.
Insuman Comb 15 is a biphasic isophane insulin suspension consisting of 15% dissolved insulin and 85% crystalline protamine insulin.
Insuman Comb 15 je dvofazna suspenzija insulina isofana, sestavljena iz 15 % raztopljenega insulina in 85 % kristalnega protamin-insulina.
Insuman Comb 15 is an insulin preparation with a gradual onset and long duration of action.
Zdravilo Insuman Comb 15 je insulinski pripravek s postopnim začetkom in dolgim trajanjem delovanja.
Insuman Comb 15 is injected under the skin 30 to 45 minutes before a meal.
Insuman Comb 15 injicirajte podkožno od 30 do 45 minut pred obrokom.
Insuman Comb 15 is injected under the skin 30 to 45 minutes before a meal.
Zdravilo Insuman Comb 15 injicirajte podkožno od 30 do 45 minut pred obrokom.
Insuman Comb 15 is supplied in cartridges for OptiClik containing 3 ml suspension (300 IU).
Zdravilo Insuman Comb 15 je na voljo v vložkih, ki vsebujejo 3 ml suspenzije (300 i.e.).
Insuman Comb 15 is supplied in pre-filled pens, OptiSet, containing 3 ml suspension, (300 IU).
Insuman Comb 15 je na voljo v napolnjenih injekcijskih peresnikih OptiSet, ki vsebujejo 3 ml suspenzije (300 i.e.).
Insuman Comb 15 is supplied in pre-filled pens, SoloStar, containing 3 ml suspension, (300 IU).
Insuman Comb 15 je na voljo v napolnjenih injekcijskih peresnikih SoloStar. ki vsebujejo 3 ml raztopine (300 i.e.).
Insuman Comb 15 is supplied in vials containing 10 ml suspension (400 IU).
Insuman Comb 15 je na voljo v vialah, ki vsebujejo 10 ml suspenzije (400 i.e.).